Requires insurers to cover brand name prescription drugs when a generic equivalent is unavailable due to a supply issue.
This bill mandates that insurers cover brand name prescription drugs when the generic equivalent is unavailable due to a supply issue recognized by the FDA. The brand name drug must be covered at the same level as the generic drug until the supply issue is resolved. This applies to insureds who are already receiving the generic drug or have a condition treated by the eligible prescription drug.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.